Introduction: Apolipoproteins and guidelines for prevention of cardiovascular disease.
Faergeman
O
O
Cardiovascular Medicine, National Heart and Lung Institute, Charing Cross Campus, Imperial College, London, UK. ferryman@mail.tele.dk
D016632:Apolipoprotein A-I / Q000097:blood; D001053:Apolipoproteins / Q000097:blood*; D001055:Apolipoproteins B / Q000097:blood; D015415:Biomarkers / Q000097:blood; D002318:Cardiovascular Diseases / Q000097:blood / Q000517:prevention & control*; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D006801:Humans; D017410:Practice Guidelines as Topic; D012307:Risk Factors
D016632:Apolipoprotein A-I; D001053:Apolipoproteins; D001055:Apolipoproteins B; D015415:Biomarkers; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL